BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling
Hanmei Bao(Tianjin Medical University Cancer Institute and Hospital), Yan Zhao(China Association for Science and Technology)
Cited by 32
Related Papers
Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways
|Frontiers in Pharmacology|2021|17